Oncologist pleads guilty in misbranded drug case; AZ relies on old friend for API;

> Oncologist Isabella Martire bought $200,000 worth of cancer drugs not approved by the FDA for her Maryland patients from an English wholesaler and sought reimbursement from Medicare, Medicaid and other insurers. Story

> Bachem will continue to supply the peptide active ingredient Goserelin to AstraZeneca for 7 more years, as it has for the past two decades. Release

> MolMed of Italy will develop a production process for GlaxoSmithKline for a late-stage investigational gene therapy for bubble boy disease, ADA-SCID.  Article

> Umetrics, a provider of multivariate analysis software, aims to bring MVA to the batch and process manufacturing industries through partnerships with drugmakers Pfizer and Biogen Idec. Article

> Inspectors from the World Health Organization are helping three Nigerian pharma companies enhance standards and operations in a step toward WHO prequalification. Story

> German contract manufacturer Aenova will lease a manufacturing unit near Lyon, France, from U.K. drugmaker SkyePharma. Story

> Cadila Pharmaceuticals (Ethiopia) has earned the cGMP certificate and claims it's the first formulation manufacturing company in Africa to comply with WHO requirements. Story

> Akela of Austin, TX, will put all energies into its contract manufacturing business, PharmaForm, following termination of a drug development effort with Japanese partner, Teikoku Seiyaku. Release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.